Truly Translational offers drug development and business development consultancy services, with access to pre-clinical lab services. Our mission is to help our customers to translate preclinical project ideas into efficient experimental plans and conclusive clinical trials. Truly Translational is founded on solid scientific expertise and more than 50 years’ experience of drug research & development in both large pharma and biotech. We help our customers to bring drug projects from preclinical in vitro studies and animal models, via common biomarker strategies, into concept testing in patients. They have solid experience in working with both small and large molecules. Their key therapeutic areas are inflammation, respiratory diseases, autoimmune diseases and oncology. As a member of the Medicon Valley Inhalation Consortium they possess access to unique competence and capabilities within inhalation, where Truly Labs offers pre-clinical in vivo inhalation pharmacology services.